Showing results (71-80 of 190) with videos related to
Sort By:
Pageof 19
Calcified Tissue International|June 1, 1991
Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type IIJ Gram, S Antonsen, M Hørder, et al.Clinical Chemistry|July 1, 1990
Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasmaS Munkvad, J Jespersen, J Sidelmann, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 1997
The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitorsJ Sidelmann, J Jespersen, C Kluft, et al.The European Respiratory Journal|May 10, 2002
Effect of inhaled heparin on lung function and coagulation in healthy volunteersK E Bendstrup, J Gram, J I JensenBone|April 1, 1995
Autosomal dominant osteopetrosis: bone mineral measurements of the entire skeleton of adults in two different subtypesE Grodum, J Gram, K Brixen, et al.American Journal of Clinical Pathology|June 1, 1985
Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-IIIJ Jespersen, J Gram, C Kluft, et al.Journal of Internal Medicine|October 1, 1990
Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endotheliumS Munkvad, J Jespersen, J Gram, et al.Journal of the American College of Cardiology|August 1, 1991
Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapyS Munkvad, J Jespersen, J Gram, et al.Journal of the American College of Cardiology|March 15, 1991
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled studyS Munkvad, J Jespersen, J Gram, et al.Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal womenJ S Madsen, S R Kristensen, J Gram, et al.Pageof 19